Latest News

Earlier this month, Apartment List announced the addition of Airbnb-friendly apartments to its platform in 25 cities, enabling renters to easily identify properties permitting Airbnb hosting and expanding this feature over time. This collaboration directly targets the increasing demand for flexible housing options among Gen Z renters, highlighted by research showing strong financial interest in home-sharing solutions. We'll assess how expanded Airbnb-friendly rental options could influence...

Earlier this month, ARTEX AG announced a strategic partnership with Abaxx Technologies to modernize the trading, financing, and management of alternative and real-world assets across regulated markets in Europe, North America, and Asia. This collaboration aims to advance market infrastructure technology and achieve cross-platform integration, positioning both firms to capitalize on growing trends in the digitization of financial markets. We'll explore how the ARTEX partnership and shared...

Jefferies reiterated a Buy rating on MBX Biosciences after the company reported strong Phase 2 data for its lead hypoparathyroidism therapy, canvuparatide, and announced an upsized public offering expected to raise approximately US$199.9 million to advance its pipeline. This influx of capital positions MBX Biosciences to pursue Phase 3 trials and regulatory interactions with both the FDA and EMA for its novel treatment. We'll examine how the successful fundraise and pipeline progress...

Earlier this week, Zacks Investment Research recommended Federal Signal as a strong growth stock, citing its top Zacks Rank and upward revisions in earnings estimates. Analysts project a 23.6% increase in the company's earnings per share this year, indicating a positive outlook compared to industry averages. We'll explore how Federal Signal's optimistic earnings forecast and Zacks endorsement could influence the company's broader investment narrative. Trump has pledged to "unleash" American...

Amneal Pharmaceuticals recently announced that the U.S. FDA has approved its generic iohexol injection (300 mg Iodine/mL), the first generic version of GE Healthcare’s Omnipaque, with plans to launch in the first quarter of 2026. This approval opens the door for Amneal to compete in a U.S. market for iohexol injections that saw approximately US$652 million in annual sales as of September 2025. We’ll explore how Amneal’s entry into the high-value generic contrast agent market could influence...

Brookfield Wealth Solutions Ltd. announced its board declared a quarterly return of capital of US$0.06 per class A and B share, payable December 31, 2025, while also reporting a very large increase in third quarter net income to US$583 million on revenues of US$2.93 billion. This sharp rise in net income despite steady revenues highlights operational efficiency and ongoing commitment to regular shareholder distributions. We'll explore how Brookfield's surge in quarterly profitability impacts...

On November 20, 2025, TFS Financial Corporation announced that its Board of Directors declared a quarterly cash dividend of $0.2825 per share, set to be paid on December 16 to shareholders of record on December 2. This dividend affirmation, paired with ongoing waivers by its mutual holding company, strengthened coverage for minority shareholders and reinforced TFS Financial's capital stability during ongoing sector challenges. We’ll explore how TFS Financial’s reliable dividend policy shapes...

Earlier this month, Lightspeed Commerce announced the appointment of Gabriel Benavides as Chief Revenue Officer and the upcoming transition of President JD Saint-Martin, who will remain until March 2026 to ensure leadership continuity. Benavides brings over 20 years of global go-to-market experience, with a history of scaling high-performing sales organizations and driving measurable revenue growth, highlighting Lightspeed's intent to bolster operational efficiency and accelerate...

In recent days, ServiceNow announced a comprehensive suite of integrations with Microsoft, Tanium, Palo Alto Networks, Aria Systems, and Camunda, aiming to expand AI-driven workflow orchestration, security, and automation capabilities across enterprise platforms. This wave of partnerships not only enables proactive management, oversight, and security of AI agents but also positions ServiceNow to address the growing demand for cross-platform enterprise AI solutions with reinforced governance...

Barrick Mining (NYSE:B) has been drawing attention recently as investors weigh its recent performance. Over the past month, the stock climbed 13%, reflecting growing interest in the resource sector as well as underlying company fundamentals. See our latest analysis for Barrick Mining. This latest rally caps off a remarkable run for Barrick Mining, whose share price has soared 39% over the past three months as investors react to renewed optimism around commodities and perceived improvements in...

u-blox Holding (SWX:UBXN) has just been dropped from the S&P Global BMI Index, a development that tends to catch the eye of investors tracking index-related funds and broader portfolio shifts. See our latest analysis for u-blox Holding. After its removal from the S&P Global BMI Index, u-blox Holding’s momentum is hard to ignore, with an 81% year-to-date share price return and a one-year total shareholder return just over 108%. While some investors are weighing the implications of this index...

Aya Gold & Silver Inc. recently commenced commercial production from a historical flotation stockpile containing precious metal-rich pyrite concentrate within its Boumadine mining license, entering into an offtake agreement to ship an estimated 2.5 million silver-equivalent ounces over the coming 20 to 24 months. This initiative not only supports environmental rehabilitation by reducing the legacy footprint but also generates cash flow to help advance the Boumadine project. We’ll examine how...

Merck (MRK) is making waves this week as the company announced a series of meaningful regulatory and clinical updates. Highlights include new FDA and European approvals, as well as encouraging clinical results for important pipeline drugs. See our latest analysis for Merck. Merck’s recent string of regulatory wins and positive clinical trial results has caught investors’ attention, with momentum clearly building. Its 1-month share price return is an impressive 11.7%, while the stock has...

Japan Hotel REIT Investment Corporation recently refinanced a JPY 1,000 million loan, securing new funding from MUFG Bank with an unsecured, unguaranteed term loan maturing in 2031. Following the refinancing, the company executed an interest rate swap to fix about 80% of its interest-bearing debt at stable rates, aiming to enhance cash flow predictability and reduce exposure to interest rate fluctuations. We’ll explore how the focus on interest rate stability through hedging impacts Japan...

Zensho Holdings (TSE:7550) moved quickly on its newly announced share repurchase plan, buying back 200,000 shares just one day after revealing the program. The rapid execution, along with a steady dividend, underscores its approach to shareholder returns. See our latest analysis for Zensho Holdings. After a turbulent month that saw the share price slide, Zensho Holdings’ rapid buyback and steady dividend have caught investor attention. While the 1-year total shareholder return sits at -4.3%,...

PJT Partners (PJT) is making a strategic move to expand in Europe, announcing plans to hire up to 10 dealmakers and open a new Stockholm office. The office will be led by former Goldman Sachs banker Thomas Westin. This signals the firm's intent to increase its local capabilities in the Nordics. See our latest analysis for PJT Partners. PJT’s expansion in the Nordics comes at a time when momentum in its share price has been uneven, with a 6.92% year-to-date gain but a recent pullback this...

The shift in Knowles (KN) stock caught attention after comments from the president of the Federal Reserve Bank of New York signaled possible rate cuts this December. Lower rates often benefit companies because they reduce financing costs and encourage investment. See our latest analysis for Knowles. Knowles shares spiked after the Fed's dovish signals, though it's been a bumpy ride. Despite a sharp move higher this week, the stock’s 1-month share price return is down 11%. That said, the...

Hub Group's Board of Directors recently declared a quarterly cash dividend of US$0.125 per share for both Class A and Class B stock, payable on December 17, 2025, to shareholders of record as of December 5, 2025, as part of its capital allocation plan. This announcement coincided with Hub Group reporting US$934.5 million in quarterly revenue, which, while showing a 5.3% year-on-year decline, exceeded analyst estimates and highlighted gains in intermodal profitability and the impact of the...

Earlier this week, Nano-X Imaging Ltd. announced a 2026 revenue outlook of US$35 million, alongside expanded commercial partnerships, including a reseller agreement with 3DR Labs and deployments in France, after unveiling its FDA-cleared Nanox.ARC X digital tomosynthesis system at RSNA 2025. This series of developments positions Nano-X Imaging for accelerated international growth and wider adoption of its AI-enhanced imaging solutions within major healthcare networks. Now, we'll explore how...

Earlier this week, GlobalFoundries and Navitas Semiconductor announced a long-term partnership to accelerate U.S.-based gallium nitride (GaN) technology development and manufacturing for high-power applications, aiming for production at GlobalFoundries' Vermont facility in late 2026. This agreement positions GlobalFoundries as an essential supplier in U.S. semiconductor supply chains for critical sectors such as AI datacenters, energy infrastructure, and industrial electrification, while...

Regeneron Pharmaceuticals (REGN) just received FDA approval for its Eylea HD 8 mg injection to treat macular edema following retinal vein occlusion. This approval offers patients the possibility of fewer required treatments compared to previous options. See our latest analysis for Regeneron Pharmaceuticals. The FDA’s green light for Eylea HD comes after a burst of momentum for Regeneron. The company has seen a 30.8% share price return over the last month alone and several promising clinical...

Commercial Metals (CMC) shares edged higher by nearly 3% in the latest session. This quiet move comes as investors continue to weigh the company's recent performance and ongoing trends in the metals sector, as they look for signs of changing momentum. See our latest analysis for Commercial Metals. Commercial Metals’ share price has quietly rallied over 20% so far this year, even as its one-year total shareholder return still lags slightly in negative territory. That mix of recent gains...

ASGN (ASGN) just announced a series of sweeping changes, including a unified Everforth brand rollout, an ambitious $1 billion share buyback, and a new AI Factory framework, all unveiled at its 2025 Investor Day. See our latest analysis for ASGN. ASGN’s big moves have captured attention, but the momentum in its share price has yet to turn around. Even after a 7.45% pop following the Investor Day announcements, the share price is still down 48% year-to-date with a one-year total shareholder...

Grocery Outlet Holding (GO) shares edged higher today, adding just over 3% at the close. Investors appear to be weighing recent performance alongside the company's annual growth in both revenue and net income as they consider its overall valuation. See our latest analysis for Grocery Outlet Holding. Even with a pop to $10.57 today, Grocery Outlet Holding's momentum has been anything but steady this year. After a double-digit drop in the past month and a hefty 45.91% decline in one-year total...